内肝胆管癌中的分类特异性瘤免疫微环境:对适当的药物治疗的影响
Masahiko Kinoshita1, Yasunori Sato2, Shoji Kubo1,3
1Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Cancers
|July 12, 2025
概括
这项研究揭示了瘤免疫微环境 (TIME) 在肝脏内胆瘤 (iCCA) 亚型中. 小导管iCCA显示较高的树突细胞透,可能导致免疫抑制的时间,并影响治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 肝脏内胆管癌 (iCCA) 有不同的小管和大管亚型.
- 亚型差异影响预后和手术策略.
- 化疗疗效果,包括免疫检查点抑制剂,可能因亚型而异.
- 瘤免疫微环境 (TIME) iCCA亚型之间的差异没有特征.
研究的目的:
- 在iCCA.中调查分类特定的TIME.
- 根据iCCA亚型,确定定制药物治疗的潜在目标.
主要方法:
- 对131例切除的ICCA病例 (73例小管,58例大管) 的分析.
- 对CD8,PD-1,PD-L1,CTLA-4和S100蛋白质 (树突细胞标记物) 的免疫组织化学分析.
主要成果:
- 大通道iCCA显示的CD8+瘤透细胞显著高于小通道iCCA.
- 小导管iCCA具有显著更高比例的瘤高S100蛋白表达 (树突细胞高).
- 在小导管iCCA中,树突细胞高瘤表现出更高的CD8,PD-1,PD-L1和CTLA-4表达.
结论:
- 在小管和大管iCCA亚型之间存在不同的TIME配置文件.
- 小导管iCCA的一个子集具有显著的树突细胞透,可能会产生免疫抑制的时间.
- 这些发现支持开发iCCA的亚型特定药物治疗方法.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.5K
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
相关概念视频
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K